AlphAIAlphAI — Financial news for AI agents
investing.comSEP 242 min read$FUL

Earnings call transcript: H.B. Fuller beats Q3 2026 EPS but shares fall

H.B. Fuller reported Q3 2026 adjusted EPS of $1.52, beating estimates by 3.4%, but revenue of $938M missed forecasts by 1.1%. The stock fell 5.94% in after-hours trading. Management maintained full-year guidance, citing pricing actions and cost controls. Challenges include soft demand in construction and electronics sectors.

Original reporting
investing.com
Published Sep 24, 2026, 3:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 3:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$FUL
Bearish
high confidence
Mentioned
$FUL
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FULBearishHigh
01

Why it matters

Earnings beat on EPS but revenue miss triggered a sharp after‑hours sell‑off, highlighting short‑term risk.

02

Market read

The earnings release provides fresh guidance and a notable price move, making it a high‑value trading event.

03

What to watch

Project Quantum Leap savings and upcoming AMS acquisition may provide longer‑term upside.

Relevance 8/10Novelty 8/10Timing: after‑hours today

Background

H.B. Fuller is a US‑listed adhesives manufacturer (ticker FUL) that posted Q3 2026 results.

Company-level read

Ticker impact

$FULBearishHigh confidence
Context

H.B. Fuller reported Q3 2026 adjusted EPS of $1.52 beating estimates, but revenue missed, causing a 5.94% after‑hours price drop.

Expected impact

Potential further decline in pre‑market trading as investors digest revenue miss; support near $47 may hold.

Evidence & confidence

The after‑hours drop and near‑52‑week low indicate immediate negative sentiment despite EPS beat.

Market effects

Sector

Adhesives sector may face pressure as revenue growth concerns spread to peers.

Regional

US industrial stocks could see modest pullback in early trading.

Global

Limited to US equities; no broader macro effect.

Counterpoint

What could challenge this read

Despite revenue miss, strong margin expansion and dividend track record could support a bounce.

Key entities

  • Executive
    Celeste Mastin

    CEO of H.B. Fuller, provided commentary on results and outlook.

Read at source← All news

Related articles

SEP 24
$FULHigh

FULLER H B CO (FUL): Results of Operations and Financial Condition

FULLER H B CO (FUL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Worldwide Headquarters 1200 Willow Lake Boulevard St. Paul, Minnesota 55110-5101 Scott Jensen Investor Relations Contact investors@hbfuller.com NEWS September 23, 2026 H.B. Fuller Reports Third Quarter 2026 Results Net revenue of $938 million, up 5.2% year-on-year; O

SEC EDGAR 8-K2 min
AUG 24
$FULMedAI 8/10

H.B. Fuller board rejects unsolicited bid

H.B. Fuller's board rejected an unsolicited bid for its BAS segment, citing a valuation below market precedent and lack of financing details. The board highlighted BAS's 6% organic growth and 10% EBITDA improvement, noting its importance for future earnings. The board also cited operational integration challenges and reaffirmed its strategic priorities, including the Advanced Medical Solutions acquisition and Project Quantum Leap.

european-coatings.com1 min
AUG 24
$FULMedAI 8/10

H.B. Fuller stock flat as board rejects Ancora’s adhesives bid

H.B. Fuller Co. (NYSE:FUL) shares were unchanged in premarket trading after its board rejected Ancora Holdings Group's $1.2 billion bid for its building adhesives unit, citing undervaluation and lack of growth potential consideration. Ancora criticized the rejection as irrational and emphasized its ability to finance a higher offer. The bid aimed to help H.B. Fuller reduce debt and focus on integrating Advanced Medical Solutions Group Plc.

investing.com1 min
AUG 13
$FULMed

AMS shareholders approve H.B. Fuller acquisition proposal

H.B. Fuller (NYSE:FUL) said Advanced Medical Solutions Group plc (LSE:AMS) shareholders approved the proposed cash acquisition of AMS. The approval is a milestone toward closing, which H.B. Fuller expects by year end, subject to remaining conditions and regulatory approvals. H.B. Fuller reported 2025 revenue of $3.5B.

investing.com2 min